Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebocontrolled clinical trial

BMC Infectious Diseases, 05/11/2012

Adjunct therapy with butyrate during shigellosis led to early reduction of inflammation and enhanced LL–37 expression in the rectal epithelia with prolonged release of LL–37 in the stool.

Print Article Summary Cat 2 CME Report